nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirbuterol—Numbness—Pravastatin—atherosclerosis	0.0183	0.0208	CcSEcCtD
Pirbuterol—Sensory loss—Pravastatin—atherosclerosis	0.0176	0.0199	CcSEcCtD
Pirbuterol—Cramp muscle—Lovastatin—atherosclerosis	0.0118	0.0133	CcSEcCtD
Pirbuterol—Cramp muscle—Ezetimibe—atherosclerosis	0.0115	0.0131	CcSEcCtD
Pirbuterol—Migraine—Niacin—atherosclerosis	0.011	0.0125	CcSEcCtD
Pirbuterol—Cramp muscle—Simvastatin—atherosclerosis	0.011	0.0125	CcSEcCtD
Pirbuterol—Clenbuterol—TNF—atherosclerosis	0.0105	0.704	CrCbGaD
Pirbuterol—Cramp muscle—Pravastatin—atherosclerosis	0.00994	0.0113	CcSEcCtD
Pirbuterol—Weight increased—Pravastatin—atherosclerosis	0.00869	0.00984	CcSEcCtD
Pirbuterol—Stomatitis—Niacin—atherosclerosis	0.00842	0.00955	CcSEcCtD
Pirbuterol—Flushing—Lovastatin—atherosclerosis	0.00838	0.0095	CcSEcCtD
Pirbuterol—Flushing—Ezetimibe—atherosclerosis	0.00822	0.00932	CcSEcCtD
Pirbuterol—Cough—Rosuvastatin—atherosclerosis	0.0081	0.00918	CcSEcCtD
Pirbuterol—Alopecia—Lovastatin—atherosclerosis	0.00798	0.00905	CcSEcCtD
Pirbuterol—Flushing—Simvastatin—atherosclerosis	0.00784	0.00889	CcSEcCtD
Pirbuterol—Alopecia—Ezetimibe—atherosclerosis	0.00783	0.00887	CcSEcCtD
Pirbuterol—Hypoaesthesia—Niacin—atherosclerosis	0.00772	0.00875	CcSEcCtD
Pirbuterol—Confusional state—Rosuvastatin—atherosclerosis	0.00764	0.00865	CcSEcCtD
Pirbuterol—Back pain—Lovastatin—atherosclerosis	0.00761	0.00862	CcSEcCtD
Pirbuterol—Hypoaesthesia—Pravastatin—atherosclerosis	0.0076	0.00861	CcSEcCtD
Pirbuterol—Muscle spasms—Lovastatin—atherosclerosis	0.00756	0.00857	CcSEcCtD
Pirbuterol—Alopecia—Simvastatin—atherosclerosis	0.00747	0.00846	CcSEcCtD
Pirbuterol—Back pain—Ezetimibe—atherosclerosis	0.00746	0.00846	CcSEcCtD
Pirbuterol—Muscle spasms—Ezetimibe—atherosclerosis	0.00742	0.0084	CcSEcCtD
Pirbuterol—Tremor—Lovastatin—atherosclerosis	0.00737	0.00835	CcSEcCtD
Pirbuterol—Flushing—Niacin—atherosclerosis	0.0072	0.00816	CcSEcCtD
Pirbuterol—Flushing—Pravastatin—atherosclerosis	0.00709	0.00804	CcSEcCtD
Pirbuterol—Muscle spasms—Simvastatin—atherosclerosis	0.00707	0.00802	CcSEcCtD
Pirbuterol—Tremor—Simvastatin—atherosclerosis	0.00689	0.00781	CcSEcCtD
Pirbuterol—Alopecia—Niacin—atherosclerosis	0.00686	0.00777	CcSEcCtD
Pirbuterol—Insomnia—Rosuvastatin—atherosclerosis	0.00685	0.00776	CcSEcCtD
Pirbuterol—Palpitations—Ezetimibe—atherosclerosis	0.00682	0.00773	CcSEcCtD
Pirbuterol—Alopecia—Pravastatin—atherosclerosis	0.00675	0.00765	CcSEcCtD
Pirbuterol—Cough—Ezetimibe—atherosclerosis	0.00673	0.00763	CcSEcCtD
Pirbuterol—Chest pain—Lovastatin—atherosclerosis	0.00669	0.00759	CcSEcCtD
Pirbuterol—Anxiety—Lovastatin—atherosclerosis	0.00667	0.00756	CcSEcCtD
Pirbuterol—Tension—Niacin—atherosclerosis	0.00663	0.00751	CcSEcCtD
Pirbuterol—Chest pain—Ezetimibe—atherosclerosis	0.00657	0.00744	CcSEcCtD
Pirbuterol—Nervousness—Niacin—atherosclerosis	0.00656	0.00743	CcSEcCtD
Pirbuterol—Dry mouth—Lovastatin—atherosclerosis	0.00655	0.00742	CcSEcCtD
Pirbuterol—Tension—Pravastatin—atherosclerosis	0.00653	0.0074	CcSEcCtD
Pirbuterol—Muscle spasms—Niacin—atherosclerosis	0.00649	0.00736	CcSEcCtD
Pirbuterol—Confusional state—Lovastatin—atherosclerosis	0.00647	0.00733	CcSEcCtD
Pirbuterol—Nervousness—Pravastatin—atherosclerosis	0.00646	0.00732	CcSEcCtD
Pirbuterol—Dry mouth—Ezetimibe—atherosclerosis	0.00642	0.00728	CcSEcCtD
Pirbuterol—Muscle spasms—Pravastatin—atherosclerosis	0.00639	0.00725	CcSEcCtD
Pirbuterol—Confusional state—Ezetimibe—atherosclerosis	0.00635	0.00719	CcSEcCtD
Pirbuterol—Chest pain—Simvastatin—atherosclerosis	0.00626	0.0071	CcSEcCtD
Pirbuterol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00624	0.00707	CcSEcCtD
Pirbuterol—Anxiety—Simvastatin—atherosclerosis	0.00624	0.00707	CcSEcCtD
Pirbuterol—Tremor—Pravastatin—atherosclerosis	0.00623	0.00706	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00619	0.00702	CcSEcCtD
Pirbuterol—Anorexia—Lovastatin—atherosclerosis	0.00612	0.00693	CcSEcCtD
Pirbuterol—Syncope—Niacin—atherosclerosis	0.00606	0.00686	CcSEcCtD
Pirbuterol—Confusional state—Simvastatin—atherosclerosis	0.00605	0.00686	CcSEcCtD
Pirbuterol—Oedema—Simvastatin—atherosclerosis	0.006	0.0068	CcSEcCtD
Pirbuterol—Abdominal pain—Rosuvastatin—atherosclerosis	0.00599	0.00679	CcSEcCtD
Pirbuterol—Palpitations—Niacin—atherosclerosis	0.00597	0.00676	CcSEcCtD
Pirbuterol—Loss of consciousness—Niacin—atherosclerosis	0.00594	0.00673	CcSEcCtD
Pirbuterol—Cough—Niacin—atherosclerosis	0.00589	0.00668	CcSEcCtD
Pirbuterol—Insomnia—Lovastatin—atherosclerosis	0.0058	0.00658	CcSEcCtD
Pirbuterol—Cough—Pravastatin—atherosclerosis	0.0058	0.00658	CcSEcCtD
Pirbuterol—Anorexia—Simvastatin—atherosclerosis	0.00572	0.00649	CcSEcCtD
Pirbuterol—Insomnia—Ezetimibe—atherosclerosis	0.00569	0.00645	CcSEcCtD
Pirbuterol—Chest pain—Pravastatin—atherosclerosis	0.00566	0.00642	CcSEcCtD
Pirbuterol—Anxiety—Pravastatin—atherosclerosis	0.00564	0.00639	CcSEcCtD
Pirbuterol—Dry mouth—Niacin—atherosclerosis	0.00562	0.00637	CcSEcCtD
Pirbuterol—Decreased appetite—Lovastatin—atherosclerosis	0.00558	0.00632	CcSEcCtD
Pirbuterol—Fatigue—Lovastatin—atherosclerosis	0.00553	0.00627	CcSEcCtD
Pirbuterol—Oedema—Niacin—atherosclerosis	0.00551	0.00625	CcSEcCtD
Pirbuterol—Confusional state—Pravastatin—atherosclerosis	0.00547	0.0062	CcSEcCtD
Pirbuterol—Decreased appetite—Ezetimibe—atherosclerosis	0.00547	0.0062	CcSEcCtD
Pirbuterol—Asthenia—Rosuvastatin—atherosclerosis	0.00543	0.00616	CcSEcCtD
Pirbuterol—Insomnia—Simvastatin—atherosclerosis	0.00543	0.00615	CcSEcCtD
Pirbuterol—Oedema—Pravastatin—atherosclerosis	0.00543	0.00615	CcSEcCtD
Pirbuterol—Fatigue—Ezetimibe—atherosclerosis	0.00543	0.00615	CcSEcCtD
Pirbuterol—Shock—Niacin—atherosclerosis	0.00542	0.00615	CcSEcCtD
Pirbuterol—Tachycardia—Niacin—atherosclerosis	0.00538	0.0061	CcSEcCtD
Pirbuterol—Pruritus—Rosuvastatin—atherosclerosis	0.00536	0.00607	CcSEcCtD
Pirbuterol—Feeling abnormal—Lovastatin—atherosclerosis	0.00529	0.00599	CcSEcCtD
Pirbuterol—Anorexia—Niacin—atherosclerosis	0.00525	0.00596	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00525	0.00595	CcSEcCtD
Pirbuterol—Decreased appetite—Simvastatin—atherosclerosis	0.00522	0.00591	CcSEcCtD
Pirbuterol—Feeling abnormal—Ezetimibe—atherosclerosis	0.00519	0.00588	CcSEcCtD
Pirbuterol—Diarrhoea—Rosuvastatin—atherosclerosis	0.00518	0.00587	CcSEcCtD
Pirbuterol—Fatigue—Simvastatin—atherosclerosis	0.00518	0.00587	CcSEcCtD
Pirbuterol—Anorexia—Pravastatin—atherosclerosis	0.00517	0.00586	CcSEcCtD
Pirbuterol—Hypotension—Niacin—atherosclerosis	0.00515	0.00584	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00515	0.00583	CcSEcCtD
Pirbuterol—Abdominal pain—Lovastatin—atherosclerosis	0.00507	0.00575	CcSEcCtD
Pirbuterol—Dizziness—Rosuvastatin—atherosclerosis	0.00501	0.00568	CcSEcCtD
Pirbuterol—Insomnia—Niacin—atherosclerosis	0.00499	0.00565	CcSEcCtD
Pirbuterol—Abdominal pain—Ezetimibe—atherosclerosis	0.00498	0.00564	CcSEcCtD
Pirbuterol—Feeling abnormal—Simvastatin—atherosclerosis	0.00495	0.00561	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00491	0.00556	CcSEcCtD
Pirbuterol—Insomnia—Pravastatin—atherosclerosis	0.00491	0.00556	CcSEcCtD
Pirbuterol—Somnolence—Niacin—atherosclerosis	0.0049	0.00555	CcSEcCtD
Pirbuterol—Decreased appetite—Niacin—atherosclerosis	0.00479	0.00543	CcSEcCtD
Pirbuterol—Rash—Rosuvastatin—atherosclerosis	0.00477	0.00541	CcSEcCtD
Pirbuterol—Dermatitis—Rosuvastatin—atherosclerosis	0.00477	0.00541	CcSEcCtD
Pirbuterol—Abdominal pain—Simvastatin—atherosclerosis	0.00475	0.00538	CcSEcCtD
Pirbuterol—Headache—Rosuvastatin—atherosclerosis	0.00474	0.00538	CcSEcCtD
Pirbuterol—Decreased appetite—Pravastatin—atherosclerosis	0.00472	0.00535	CcSEcCtD
Pirbuterol—Fatigue—Pravastatin—atherosclerosis	0.00468	0.0053	CcSEcCtD
Pirbuterol—Asthenia—Lovastatin—atherosclerosis	0.0046	0.00522	CcSEcCtD
Pirbuterol—Pruritus—Lovastatin—atherosclerosis	0.00454	0.00515	CcSEcCtD
Pirbuterol—Asthenia—Ezetimibe—atherosclerosis	0.00452	0.00512	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Niacin—atherosclerosis	0.00451	0.00511	CcSEcCtD
Pirbuterol—Nausea—Rosuvastatin—atherosclerosis	0.0045	0.0051	CcSEcCtD
Pirbuterol—Feeling abnormal—Pravastatin—atherosclerosis	0.00447	0.00507	CcSEcCtD
Pirbuterol—Pruritus—Ezetimibe—atherosclerosis	0.00445	0.00505	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00444	0.00503	CcSEcCtD
Pirbuterol—Epinephrine—TNF—atherosclerosis	0.00442	0.296	CrCbGaD
Pirbuterol—Diarrhoea—Lovastatin—atherosclerosis	0.00439	0.00498	CcSEcCtD
Pirbuterol—Abdominal pain—Niacin—atherosclerosis	0.00436	0.00494	CcSEcCtD
Pirbuterol—Asthenia—Simvastatin—atherosclerosis	0.00431	0.00488	CcSEcCtD
Pirbuterol—Diarrhoea—Ezetimibe—atherosclerosis	0.00431	0.00488	CcSEcCtD
Pirbuterol—Abdominal pain—Pravastatin—atherosclerosis	0.00429	0.00486	CcSEcCtD
Pirbuterol—Pruritus—Simvastatin—atherosclerosis	0.00425	0.00481	CcSEcCtD
Pirbuterol—Dizziness—Lovastatin—atherosclerosis	0.00424	0.00481	CcSEcCtD
Pirbuterol—Dizziness—Ezetimibe—atherosclerosis	0.00416	0.00472	CcSEcCtD
Pirbuterol—Diarrhoea—Simvastatin—atherosclerosis	0.00411	0.00466	CcSEcCtD
Pirbuterol—Vomiting—Lovastatin—atherosclerosis	0.00408	0.00463	CcSEcCtD
Pirbuterol—Rash—Lovastatin—atherosclerosis	0.00405	0.00459	CcSEcCtD
Pirbuterol—Dermatitis—Lovastatin—atherosclerosis	0.00404	0.00458	CcSEcCtD
Pirbuterol—Headache—Lovastatin—atherosclerosis	0.00402	0.00456	CcSEcCtD
Pirbuterol—Vomiting—Ezetimibe—atherosclerosis	0.004	0.00454	CcSEcCtD
Pirbuterol—Dizziness—Simvastatin—atherosclerosis	0.00397	0.0045	CcSEcCtD
Pirbuterol—Rash—Ezetimibe—atherosclerosis	0.00397	0.0045	CcSEcCtD
Pirbuterol—Dermatitis—Ezetimibe—atherosclerosis	0.00397	0.00449	CcSEcCtD
Pirbuterol—Asthenia—Niacin—atherosclerosis	0.00395	0.00448	CcSEcCtD
Pirbuterol—Headache—Ezetimibe—atherosclerosis	0.00394	0.00447	CcSEcCtD
Pirbuterol—Pruritus—Niacin—atherosclerosis	0.0039	0.00442	CcSEcCtD
Pirbuterol—Asthenia—Pravastatin—atherosclerosis	0.00389	0.00441	CcSEcCtD
Pirbuterol—Pruritus—Pravastatin—atherosclerosis	0.00384	0.00435	CcSEcCtD
Pirbuterol—Vomiting—Simvastatin—atherosclerosis	0.00382	0.00433	CcSEcCtD
Pirbuterol—Nausea—Lovastatin—atherosclerosis	0.00381	0.00432	CcSEcCtD
Pirbuterol—Rash—Simvastatin—atherosclerosis	0.00378	0.00429	CcSEcCtD
Pirbuterol—Dermatitis—Simvastatin—atherosclerosis	0.00378	0.00429	CcSEcCtD
Pirbuterol—Diarrhoea—Niacin—atherosclerosis	0.00377	0.00427	CcSEcCtD
Pirbuterol—Headache—Simvastatin—atherosclerosis	0.00376	0.00426	CcSEcCtD
Pirbuterol—Nausea—Ezetimibe—atherosclerosis	0.00374	0.00424	CcSEcCtD
Pirbuterol—Diarrhoea—Pravastatin—atherosclerosis	0.00371	0.00421	CcSEcCtD
Pirbuterol—Dizziness—Niacin—atherosclerosis	0.00364	0.00413	CcSEcCtD
Pirbuterol—Dizziness—Pravastatin—atherosclerosis	0.00359	0.00407	CcSEcCtD
Pirbuterol—Nausea—Simvastatin—atherosclerosis	0.00357	0.00404	CcSEcCtD
Pirbuterol—Vomiting—Niacin—atherosclerosis	0.0035	0.00397	CcSEcCtD
Pirbuterol—Rash—Niacin—atherosclerosis	0.00348	0.00394	CcSEcCtD
Pirbuterol—Dermatitis—Niacin—atherosclerosis	0.00347	0.00394	CcSEcCtD
Pirbuterol—Headache—Niacin—atherosclerosis	0.00345	0.00391	CcSEcCtD
Pirbuterol—Vomiting—Pravastatin—atherosclerosis	0.00345	0.00391	CcSEcCtD
Pirbuterol—Rash—Pravastatin—atherosclerosis	0.00342	0.00388	CcSEcCtD
Pirbuterol—Dermatitis—Pravastatin—atherosclerosis	0.00342	0.00387	CcSEcCtD
Pirbuterol—Headache—Pravastatin—atherosclerosis	0.0034	0.00385	CcSEcCtD
Pirbuterol—Nausea—Niacin—atherosclerosis	0.00327	0.00371	CcSEcCtD
Pirbuterol—Nausea—Pravastatin—atherosclerosis	0.00322	0.00365	CcSEcCtD
Pirbuterol—ADRB1—GPCR ligand binding—CX3CL1—atherosclerosis	0.000457	0.00445	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CX3CR1—atherosclerosis	0.000456	0.00444	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CASR—atherosclerosis	0.000456	0.00444	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CX3CL1—atherosclerosis	0.000447	0.00435	CbGpPWpGaD
Pirbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000443	0.00431	CbGpPWpGaD
Pirbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000443	0.00431	CbGpPWpGaD
Pirbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.00044	0.00427	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—CNR2—atherosclerosis	0.000434	0.00422	CbGpPWpGaD
Pirbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000433	0.00421	CbGpPWpGaD
Pirbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000433	0.00421	CbGpPWpGaD
Pirbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000432	0.0042	CbGpPWpGaD
Pirbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.00043	0.00418	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—HRH1—atherosclerosis	0.000427	0.00415	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CNR2—atherosclerosis	0.000424	0.00413	CbGpPWpGaD
Pirbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000422	0.00411	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—HRH1—atherosclerosis	0.000417	0.00406	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—HRH1—atherosclerosis	0.000387	0.00377	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—HRH1—atherosclerosis	0.000379	0.00369	CbGpPWpGaD
Pirbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.000379	0.00368	CbGpPWpGaD
Pirbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.000377	0.00366	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—CCL3—atherosclerosis	0.000373	0.00363	CbGpPWpGaD
Pirbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.000371	0.0036	CbGpPWpGaD
Pirbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.000368	0.00358	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CCL3—atherosclerosis	0.000365	0.00355	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—EDNRA—atherosclerosis	0.000337	0.00328	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—CCR2—atherosclerosis	0.000337	0.00328	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CCR2—atherosclerosis	0.00033	0.00321	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—EDNRA—atherosclerosis	0.00033	0.00321	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—GHRL—atherosclerosis	0.000329	0.0032	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—GHRL—atherosclerosis	0.000321	0.00313	CbGpPWpGaD
Pirbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.000319	0.0031	CbGpPWpGaD
Pirbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000317	0.00308	CbGpPWpGaD
Pirbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.000312	0.00304	CbGpPWpGaD
Pirbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.00031	0.00301	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—KNG1—atherosclerosis	0.000288	0.00281	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—AGTR1—atherosclerosis	0.000287	0.00279	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—KNG1—atherosclerosis	0.000282	0.00274	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—AGTR1—atherosclerosis	0.000281	0.00273	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CCL4—atherosclerosis	0.00028	0.00272	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—UTS2—atherosclerosis	0.000275	0.00267	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CCL4—atherosclerosis	0.000274	0.00267	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—UTS2—atherosclerosis	0.000269	0.00262	CbGpPWpGaD
Pirbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000265	0.00258	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CASR—atherosclerosis	0.000264	0.00256	CbGpPWpGaD
Pirbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000259	0.00252	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CASR—atherosclerosis	0.000258	0.00251	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—UTS2—atherosclerosis	0.00025	0.00243	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CNR2—atherosclerosis	0.000245	0.00238	CbGpPWpGaD
Pirbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000245	0.00238	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—UTS2—atherosclerosis	0.000244	0.00238	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—EDN1—atherosclerosis	0.000243	0.00236	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—CCL5—atherosclerosis	0.000241	0.00235	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CNR2—atherosclerosis	0.00024	0.00233	CbGpPWpGaD
Pirbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.00024	0.00233	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CX3CR1—atherosclerosis	0.000239	0.00233	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CASR—atherosclerosis	0.000239	0.00233	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—EDN1—atherosclerosis	0.000238	0.00231	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CCL5—atherosclerosis	0.000236	0.00229	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CX3CL1—atherosclerosis	0.000235	0.00228	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CX3CR1—atherosclerosis	0.000234	0.00228	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CASR—atherosclerosis	0.000234	0.00228	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CX3CL1—atherosclerosis	0.00023	0.00223	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HRH1—atherosclerosis	0.000229	0.00223	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HRH1—atherosclerosis	0.000224	0.00218	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CNR2—atherosclerosis	0.000223	0.00216	CbGpPWpGaD
Pirbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000218	0.00212	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CNR2—atherosclerosis	0.000218	0.00212	CbGpPWpGaD
Pirbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000213	0.00208	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—AGT—atherosclerosis	0.000202	0.00196	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—AGT—atherosclerosis	0.000197	0.00192	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CCL3—atherosclerosis	0.000191	0.00186	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CCR2—atherosclerosis	0.000191	0.00185	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000191	0.00185	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CCL3—atherosclerosis	0.000187	0.00182	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—F2—atherosclerosis	0.000186	0.00181	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—EDNRA—atherosclerosis	0.000186	0.00181	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CCR2—atherosclerosis	0.000186	0.00181	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—GHRL—atherosclerosis	0.000186	0.00181	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—F2—atherosclerosis	0.000182	0.00177	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—GHRL—atherosclerosis	0.000182	0.00177	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APOA4—atherosclerosis	0.00018	0.00175	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APOA4—atherosclerosis	0.000176	0.00171	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—EDNRA—atherosclerosis	0.000173	0.00168	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CCR2—atherosclerosis	0.000173	0.00168	CbGpPWpGaD
Pirbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000173	0.00168	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—EDNRA—atherosclerosis	0.000169	0.00165	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CCR2—atherosclerosis	0.000169	0.00165	CbGpPWpGaD
Pirbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000169	0.00164	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—GHRL—atherosclerosis	0.000169	0.00164	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—CCL2—atherosclerosis	0.000166	0.00162	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCL4—atherosclerosis	0.000165	0.00161	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—GHRL—atherosclerosis	0.000165	0.0016	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—KNG1—atherosclerosis	0.000163	0.00159	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CCL2—atherosclerosis	0.000163	0.00158	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000162	0.00158	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCL4—atherosclerosis	0.000162	0.00157	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—KNG1—atherosclerosis	0.000159	0.00155	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000159	0.00154	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APOA2—atherosclerosis	0.000155	0.0015	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APOA2—atherosclerosis	0.000151	0.00147	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—KNG1—atherosclerosis	0.000148	0.00144	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—UTS2—atherosclerosis	0.000147	0.00143	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AGTR1—atherosclerosis	0.000147	0.00143	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—KNG1—atherosclerosis	0.000145	0.00141	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—UTS2—atherosclerosis	0.000144	0.0014	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AGTR1—atherosclerosis	0.000144	0.0014	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CX3CR1—atherosclerosis	0.000141	0.00138	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CASR—atherosclerosis	0.000141	0.00138	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CX3CL1—atherosclerosis	0.000139	0.00135	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CX3CR1—atherosclerosis	0.000138	0.00135	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CASR—atherosclerosis	0.000138	0.00135	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—EDN1—atherosclerosis	0.000137	0.00134	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CCL5—atherosclerosis	0.000136	0.00133	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CX3CL1—atherosclerosis	0.000136	0.00132	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	0.000134	0.00131	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	0.000133	0.0013	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CNR2—atherosclerosis	0.000131	0.00128	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—CXCL8—atherosclerosis	0.000131	0.00128	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—MMP3—atherosclerosis	0.000131	0.00128	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PRKCG—atherosclerosis	0.00013	0.00126	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CNR2—atherosclerosis	0.000129	0.00125	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	0.000129	0.00125	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	0.000128	0.00125	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000127	0.00123	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—EDN1—atherosclerosis	0.000125	0.00121	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	0.000124	0.0012	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	0.000122	0.00119	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	0.000121	0.00118	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	0.000118	0.00114	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—VWF—atherosclerosis	0.000117	0.00114	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APOC3—atherosclerosis	0.000116	0.00113	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—LDLR—atherosclerosis	0.000116	0.00113	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	0.000115	0.00112	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—VWF—atherosclerosis	0.000115	0.00111	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	0.000114	0.00111	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	0.000114	0.00111	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	0.000113	0.0011	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	0.000113	0.0011	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	0.000112	0.00108	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	0.000111	0.00108	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	0.000108	0.00105	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	0.000106	0.00103	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	0.000105	0.00102	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	0.000104	0.00101	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	0.000103	0.001	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	0.000102	0.000994	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	0.000102	0.000994	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	0.000102	0.00099	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	0.000101	0.000985	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000101	0.000981	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	0.0001	0.000973	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	0.0001	0.000973	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	9.96e-05	0.000969	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	9.96e-05	0.000969	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	9.96e-05	0.000969	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	9.96e-05	0.000968	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	9.86e-05	0.000959	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	9.75e-05	0.000948	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	9.75e-05	0.000948	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	9.75e-05	0.000948	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—F2—atherosclerosis	9.57e-05	0.000931	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—F2—atherosclerosis	9.36e-05	0.00091	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	9.16e-05	0.000891	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	8.96e-05	0.000871	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	8.75e-05	0.000851	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	8.69e-05	0.000845	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	8.55e-05	0.000832	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	8.53e-05	0.000829	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	8.5e-05	0.000827	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PLG—atherosclerosis	8.47e-05	0.000824	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	8.34e-05	0.000811	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PLG—atherosclerosis	8.29e-05	0.000806	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	8.02e-05	0.00078	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	7.85e-05	0.000763	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	7.75e-05	0.000754	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	7.71e-05	0.00075	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	7.58e-05	0.000737	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	7.55e-05	0.000734	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APOB—atherosclerosis	7.49e-05	0.000728	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	7.42e-05	0.000722	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	7.37e-05	0.000717	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APOB—atherosclerosis	7.33e-05	0.000712	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	7.31e-05	0.000711	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	7.26e-05	0.000706	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	7.21e-05	0.000701	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	7.15e-05	0.000696	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—LPL—atherosclerosis	7.15e-05	0.000695	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—LPL—atherosclerosis	6.99e-05	0.00068	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	6.95e-05	0.000676	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	6.8e-05	0.000661	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	6.77e-05	0.000659	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	6.74e-05	0.000656	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	6.62e-05	0.000644	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	6.6e-05	0.000641	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	6.27e-05	0.000609	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	6.13e-05	0.000596	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AGT—atherosclerosis	6.12e-05	0.000595	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APOE—atherosclerosis	5.99e-05	0.000583	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—LEP—atherosclerosis	5.99e-05	0.000583	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AGT—atherosclerosis	5.98e-05	0.000582	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	5.94e-05	0.000578	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	5.92e-05	0.000576	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—LEP—atherosclerosis	5.86e-05	0.00057	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APOE—atherosclerosis	5.86e-05	0.00057	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	5.81e-05	0.000565	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	5.8e-05	0.000564	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	5.72e-05	0.000557	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—F2—atherosclerosis	5.65e-05	0.00055	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	5.6e-05	0.000544	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—F2—atherosclerosis	5.53e-05	0.000538	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	5.41e-05	0.000526	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	5.29e-05	0.000515	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	5.18e-05	0.000504	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—INS—atherosclerosis	5.12e-05	0.000498	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	5.07e-05	0.000493	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	5.04e-05	0.00049	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—INS—atherosclerosis	5.01e-05	0.000487	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	4.95e-05	0.000482	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	4.93e-05	0.000479	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	4.84e-05	0.000471	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	4.7e-05	0.000457	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	4.6e-05	0.000447	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	4.49e-05	0.000437	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	4.39e-05	0.000427	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	3.98e-05	0.000387	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	3.9e-05	0.000379	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	3.85e-05	0.000374	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	3.79e-05	0.000368	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	3.76e-05	0.000366	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	3.7e-05	0.00036	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	3.6e-05	0.00035	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	3.56e-05	0.000347	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	3.52e-05	0.000343	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	3.5e-05	0.000341	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	3.49e-05	0.00034	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	3.49e-05	0.000339	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	3.43e-05	0.000333	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	3.42e-05	0.000332	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	3.23e-05	0.000315	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	3.2e-05	0.000312	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	3.16e-05	0.000308	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	3.13e-05	0.000305	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	3.06e-05	0.000298	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	2.99e-05	0.000291	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	2.97e-05	0.000289	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	2.9e-05	0.000282	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IL6—atherosclerosis	2.24e-05	0.000218	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IL6—atherosclerosis	2.19e-05	0.000213	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	2.06e-05	0.000201	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	2.02e-05	0.000196	CbGpPWpGaD
